Verzenio: 2019 Drug Insight Report - ResearchAndMarkets.com

DUBLIN--()--The "Verzenio - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive information of the drug, Verzenio.

It includes drugs overview, Verzenio mechanism of action, clinical trials, regulatory milestones, deals & Verzenio's partnerships. It further provides Verzenio's patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India. It also features the historical and forecasted Verzenio sales till 2021. The report also throws light on Verzenio market competition and emerging therapies in the same space as Verzenio. Verzenio SWOT analysis is also featured.

Scope of the Report

  • A comprehensive Verzenio overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Verzenio Patent information in United States (US) and Europe (EU) has been highlighted
  • Verzenio API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Verzenio sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Verzenio operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features a Verzenio SWOT analysis

Reasons to Buy

  • Establish a comprehensive understanding of the drug, Verzenio
  • Access to Verzenio API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Verzenio patents for the major markets - US and EU
  • Understand current and future Verzenio's growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Verzenio
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Verzenio
  • Identify opportunities in the same area as with Verzenio SWOT analysis

Key Topics Covered

1. Report Introduction

2. Verzenio - Overview

  • Verzenio Product Description
  • Verzenio Route of Synthesis
  • Verzenio Mechanism of Action
  • Verzenio Pharmacology
  • Verzenio Pharmacodynamics
  • Verzenio Pharmacokinetics
  • Verzenio Adverse Reactions
  • Verzenio Clinical Trials
  • Verzenio Regulatory Milestones
  • Verzenio Development Activities

3. Global API Manufacturers

  • United States
  • Europe
  • China
  • India

4. Product Details

  • United States
  • Europe

5. Verzenio Global Sales Assessment

  • Verzenio Sales Global(Historical)
  • Verzenio Sales Global(Forecasted)

6. Verzenio Patent Details

7. Verzenio Market Competition

8. Verzenio Emerging Therapies

8.1. Drug name: Company name

  • Product Description
  • Research & Development
  • Product Development Activities

9. Verzenio SWOT Analysis

List of Tables

Table 1: Verzenio, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Verzenio Product Details, United States

Table 8: Verzenio Product Details, Europe

Table 9: Verzenio, Historical Global Sales till 2017 (in million USD)

Table 10: Verzenio, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Verzenio

Table 12: Verzenio Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Verzenio

Figure 2: Verzenio, Historical Global Sales till 2017 (in million USD)

Figure 3: Verzenio, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Verzenio

Figure 5: API Manufacturers Region wise

For more information about this report visit https://www.researchandmarkets.com/r/qkn9u5

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900